1SIEGEL R, NAISHADHAM D, JEMAL A. Cancer Statistics, 2013[J]. CCJ Clin, 2013,63:11-30.
2ROUPRI~T M, BABJUK M, COMPERAT E, et al. European Association of Urology guidelines on upper urinary tract Urothe- lial Cell Carcinoma : 2015 Update~J]. Eur Ulol, 2015,68 (5) : 868-879.
3M. HOLLSTEIN MM, A.P. GROLLMAN, M. OLIVIER. A- nalysis of TP53 mutation spectra reveals the fingerprint of the potent environmental carcinogen, aristolochic acid[J]. Mutation Res, 2013,(753): 41-49.
6VANHERWEGHEM, JEAN-LOUIS, DEPIERREUX, et al. Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbsEJ~.Lancet, 1993,341(8842) :387-391.
7ANANDAGODA N, LORD GM. Clin J Am Soc NephrolPreven- ring Aristolochic Acid Nephropathy[J], Clin J Am Soc Nephrol, 2015,10(2) : 167-168.
8YUN BH, SIDORENKO VS, ROSENQUIST TA, et al. New approaches for biomonitoring exposure to the human carcinogen aristolochic acid[J]. Toxicol Res (Camb), 2015,4(4) :763-776.
9BOJAN JELAKOVIC, JOVAN NIKOLIg, ZORAN RADOVANOVIC, et al. Consensus statement on screening, di- agnosis, classification and treatment of endemic (Balkan) ne- phropathy[J]. Nephrol Dial Transpl, 2014,29(11) :2020-2027.
10JOE:LLEL. NORTIER, MARIE-CARMEN MUNIZ MARTIN- EZ, HEINZ H. SCHMEISER, et al. Urothelial carcinoma asso- ciated with the use of a Chinese herb (Aristolochia fangchi)[J]. N Engl J Med, 2000,342(23) ~ 1686-1692.
